12th pharmacovigilance stakeholder forum

EventHumanRegulatory and procedural guidancePharmacovigilance

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

Date: poniedziałek, 24 Wrzesień 2018, Cały dzień
Miejsce: European Medicines Agency, Amsterdam, the Netherlands

This forum brings together regulators with patients, healthcare professionals and the pharmaceutical industry, to take stock of what we have achieved and what needs to be the focus over the coming years.

Video

Documents

Agenda – 12th Pharmacovigilance stakeholder forum

Reference Number: EMA/274125/2018

English (EN) (75.95 KB - PDF)

Opublikowane po raz pierwszy: 19/09/2018 Ostatnia aktualizacja: 02/10/2018

List of participants: 12th stakeholder forum on the pharmacovigilance legislation

Reference Number: EMA/505196/2018

English (EN) (83.22 KB - PDF)

Opublikowane po raz pierwszy: 05/10/2018

Presentation - Pharmacovigilance in 2018 (P. Arlett)

English (EN) (2.56 MB - PDF)

Opublikowane po raz pierwszy: 05/10/2018

Presentation - Overview of current patient involvement (M. Mavris)

English (EN) (1.15 MB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Public Hearings; experience so far (N. Bere)

English (EN) (318.9 KB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - The engagement of patients and healthcare professionals in regulatory pharmacovigilance: developing a conceptualisation (P. Brown)

English (EN) (1.18 MB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Valproate case study: industry perspective (E. Teo)

English (EN) (172.44 KB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Public hearing on valproate: Account of events and outcomes (E. Vatzaki)

English (EN) (181.97 KB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Valproate case study: patients' perspective (F.Houyez)

English (EN) (2.84 MB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Valproate case study: pharmacists' perspective (R. Anderson)

English (EN) (892.25 KB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Valproate case study: doctors' perspective (R. Kalvianen)

English (EN) (921.29 KB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Valproate case study: engagement of patients and healthcare professionals (P. Bahri)

English (EN) (245.16 KB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, doctors' vision (C. Matias)

English (EN) (730.35 KB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, pharmacists' vision (J. De Belie)

English (EN) (658.34 KB - PDF)

Opublikowane po raz pierwszy: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, industry vision (V. Edwards)

English (EN) (1.12 MB - PDF)

Opublikowane po raz pierwszy: 08/10/2018